SOCIETAL CDMO, INC.

Analyst Reco. Societal CDMO, Inc.

Equities

SCTL

US75629F1093

Market Closed - Nyse Other stock markets 16:00:00 2024-04-05 EDT			5-day change	1st Jan Change
1.1 ^USD	+0.92%		0.00%	+213.84%

04-08	Societal CDMO, Inc. Announces Board and Committee Resignations	CI
04-08	Societal CDMO, Inc.(NasdaqCM:SCTL) dropped from NASDAQ Composite Index	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stephens Downgrades Societal CDMO to Equalweight From Overweight, Raises Price Target to $1.10 From $1	02-29	MT
William Blair Downgrades Societal CDMO to Market Perform From Outperform	02-29	MT
RBC Downgrades Societal CDMO to Sector Perform From Outperform, Trims Price Target to $1.10 From $1.25 Amid CoreRx Deal	02-29	MT
RBC Cuts Price Target on Societal CDMO to $1.25 From $2, Keeps Outperform Rating	11-09	MT
Craig Hallum Cuts Societal CDMO Price Target to $4 From $6, Maintains Buy Rating	23-08-28	MT
RECRO PHARMA : William Blair Initiates Coverage on Recro Pharma With Outperform Rating	21-10-12	MT
RECRO PHARMA : Craig Hallum Initiates Coverage on Recro Pharma With Buy Rating, $6 Price Target	21-01-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer